Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Taysha Gene Therapies (TSHA) Prepaid Assets: 2022-2025

Historic Prepaid Assets for Taysha Gene Therapies (TSHA) over the last 4 years, with Sep 2025 value amounting to $2.2 million.

  • Taysha Gene Therapies' Prepaid Assets fell 36.86% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year decrease of 36.86%. This contributed to the annual value of $2.6 million for FY2024, which is 23.97% down from last year.
  • Per Taysha Gene Therapies' latest filing, its Prepaid Assets stood at $2.2 million for Q3 2025, which was down 29.34% from $3.1 million recorded in Q2 2025.
  • Taysha Gene Therapies' 5-year Prepaid Assets high stood at $10.6 million for Q2 2022, and its period low was $2.2 million during Q3 2025.
  • Its 3-year average for Prepaid Assets is $4.5 million, with a median of $3.5 million in 2023.
  • Data for Taysha Gene Therapies' Prepaid Assets shows a maximum YoY tumbled of 63.71% (in 2024) over the last 5 years.
  • Over the past 4 years, Taysha Gene Therapies' Prepaid Assets (Quarterly) stood at $8.5 million in 2022, then slumped by 59.25% to $3.5 million in 2023, then dropped by 23.97% to $2.6 million in 2024, then plummeted by 36.86% to $2.2 million in 2025.
  • Its Prepaid Assets stands at $2.2 million for Q3 2025, versus $3.1 million for Q2 2025 and $3.7 million for Q1 2025.